Diabetes News

Unite for diabetes

Take 10 seconds to share your support for a UN Resolution on diabetes. Diabetes kills over 3.5 million every year. Take 10 seconds to show your support for a UN Resolution on diabetes. Diabetes is a global problem. More than 230 million people live with diabetes. If nothing is done, this figure will exceed 350 million within a generation and undermine the benefits of improved standards of living worldwide. The world needs a UN Resolution on diabetes to bring this silent killer out of the shadows. Please visit this link to Unite for Diabetes - the campaign website and sign the petition.

Breaking News: FDA Approves Inhaled Insulin (Exubera) for
Controlling Type 1 & 2 diabetes.

January 27, 2006

Exubera was found in clinical trials to be as effective as short-acting insulin injections, and to improve blood sugar control when added to diabetes pills.

Exubera will be available for patients by mid-year. 

If you would like to know more about Exubera please contact Pfizer at 1-800-EXUBERA. 

Pfizer News

Source: Pfizer

New Drug on the Market: SYMLIN(pramlintide acetate injection)

People with diabetes do not make any or enough of natural hormone amylin.  Without the amylin, sugar enters the blood too quickly following meals, producing peaks in blood glucose levels after meals.  SYMLIN is an injectable medicine for adults with type 2 or type 1 diabetes to control blood sugar.

Amylin works with the insulin to control how quickly sugar enters the bloodstream from the stomach and intestines.